Ropinirole
Ropinirole Hydrochloride is a prescription medication available as extended-release oral tablets in strengths of 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg. It's a generic dopamine agonist used to treat symptoms of Parkinson's disease and restless legs syndrome. Manufactured by Alembic Pharmaceuticals Inc. under ANDA202786. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ropinirole Hydrochloride is a prescription medication available as extended-release oral tablets in strengths of 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg. It's a generic dopamine agonist used to treat symptoms of Parkinson's disease and restless legs syndrome. Manufactured by Alembic Pharmaceuticals Inc. under ANDA202786. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ropinirole",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ropinirole — ANDA 090429 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090429"
}
]
|
| identifier | ANDA090429 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"health-care",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ropinirole |
